ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

After a “humble” start at NCI, von Eschenbach set unachievable goal.

September 30, 2005

In Brief: ONS Lectures Announced; Brennan To Retire As Michigan Cancer Foundation President

April 19, 1991

NCI Developing Plan To Replace Research Contracts At Academic Institutions With “Program Grants”

February 22, 1974

RFAs Available.

July 4, 2003

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

MSKCC hopes to raise $1 billion in five-year campaign.

November 7, 2003